Beam Therapeutics Inc.
BEAM
Jodie situation report
Beam Therapeutics Inc.'s move is being confirmed by its market group.
BEAM accounts for 3.6% of the group's measured movement across 6.0 effective names. raw member direction is mixed; 6 of 8 SPY-adjusted paths align to the downside. Capital-flow agreement is 15%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
BBIO, ARWR, CGON moved materially before BEAM. BEAM crossed its material path threshold at 12:05 ET, 60 minutes after the first measured mover.
5 of 8 members in Gene Editing Therapies are active. 0 of 8 disclosed connections are confirming.
- At least 6 of 8 durable members become active together.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as RLYB begins moving with the group.
Invalidation: The live read weakens if participation falls to 2 of 8 members or fewer.
Who this business touches
The relationships behind BEAM
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
LLYEli Lilly and CompanypartnerMay 7, 2026 ▾
“Verve Therapeutics and Eli Lilly and Company We are party to a license agreement, or the Verve Agreement, with Verve Therapeutics, Inc., or Verve, pursuant to which we granted Verve exclusive worldwide licenses under our base editing technologies for human th…”
BMYBristol-Myers Squibb CompanypartnerMay 7, 2026 ▾
“Orbital Therapeutics and Bristol Myers Squibb Company We are party to a license agreement, or the Orbital Agreement, with Orbital, pursuant to which each of us have granted the other non-exclusive licenses to certain technology that is necessary or reasonably…”
Depended on by
SANASana Biotechnology, Inc.partnerMay 11, 2026 ▾
“Our ex vivo and in vivo technologies represent an aggregation of years of innovation and technology from multiple academic institutions and companies, including hypoimmune technology licensed from the President and Fellows of Harvard College (Harvard) and The…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 5 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
BEAM is currently a Follower in the organic co-movement group Gene Editing Therapies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.